Severe respiratory failure and Torsades de Pointes induced by disopyramide in a patient with myasthenia gravis

Internal Medicine

Volumn 47, Issue 19, 2008, Pages 1703-1708

  Hirose, Kayo ^a   Yamaguchi, Hiroshi ^a   Oshima, Yasushi ^a   Choraku, Masahito ^a   Hirono, Akira ^a   Takamori, Nobuyuki ^a   Tamura, Katsuya ^a  

^a Health Insurance Naruto Hospital   (Japan)

Author keywords

Class 1a anti arrhythmic drugs; Disopyramide; Long QT syndrome; Myasthenia gravis

Indexed keywords

CHOLINESTERASE INHIBITOR; DISOPYRAMIDE; FUROSEMIDE; LIDOCAINE; MAGNESIUM; PREDNISOLONE; VERAPAMIL; WARFARIN;

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MYASTHENIA GRAVIS; OUTCOME ASSESSMENT; PATIENT TRANSPORT; QT PROLONGATION; RESPIRATORY FAILURE; TORSADE DES POINTES; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CHOLINERGIC ANTAGONISTS; DISOPYRAMIDE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MIDDLE AGED; MYASTHENIA GRAVIS; RESPIRATORY INSUFFICIENCY; TORSADES DE POINTES;

EID: 56349085504     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0976     Document Type: Article

References (15)

1. Feldman S, Karalliedde L. Drug interactions with neuromuscular blockers. Drug Saf 15: 261-273, 1996.
2. Similowski T, Straus C, Attali V, et al. Neuromuscular blockade with acute respiratory failure in a patient receiving Cibenzoline. Thorax 52: 582-584, 1997.
3. Wakutani Y, Matsushima E, Son A, Shimizu Y, Goto Y, Ishida H. Myasthenialike syndrome due to adverse effects of cibenzoline in a patient with chronic renal failure. 21: 416-417, 1998.
4. Ozasa Y, Takamura S, Seishi I, Kitada H, Uekihara S, Hayano S. A case of acute cibenzoline intoxication in a hemodialysis patient. Chudoku Kenkyu 16: 335-338, 2003 (in Japanese, Abstract in English).
5. Inada K, Sekita G, Sawaki D, et al. A case of severe respiratory depression due to Cibenzoline overdosage induced by a transient renal dysfunction. Int J Cardiol 82: 177-178, 2002.
6. Kasuga A, Maruyama H, Sato T, Nogawa S, Mitamura H, Saruta T. Myasthenia-like syndrome induced by overdosage of cibenzoline. Intern Med 35: 512-514, 1996.
7. Sekioka T, Kawanishi T, Noguchi A, Matsuura T, Akiguchi I, Kameyama M. Crisis of myasthenia gravis induced by the administration of disopyramide. Shinkeinaika 18: 95, 1983 (in Japanese).
8. Yamamoto N, Ozaki T, Keida Y, Ohtsuka M, Goto T. A comparison of the binding characteristics of class 1 antiarrhythmic agents for human muscarinic m1 m3 receptors. J Cardiovasc Pharmacol 34: 53-59, 1999.
9. Garcia N, Santafe MM, Salon I, Lanuza MA, Tomas J. Expression of muscarinic acetylcholine receptors (M1-, M2-, M3- and M4-type) in the neuromuscular junction of the newborn and adult rat. Histol Histopathol 220: 733-743, 2005.
10. Hofstad H, Ohm OJ, Mork SJ, Aarli JA. Heart disease in myasthenia gravis. Acta Neurol Scand 70: 176-184, 1984.
11. Cubeddu LX. QT prolongation and fatal arrhythmias: a review of clinical implications and effect of drugs. Am J Ther 10: 452-457, 2003.
12. Golzari H, Dawson NV, Speroff T, Thomas C. Prolomged QTc intervals on admission electrocardiograms: prevalence and correspondence with admission electrolyte abnormalities. Conn Med 71: 389-397, 2007.
13. Stanescu C, Branidou K. Takotsubo cardiomyopathy. Rom J Intern Med 44: 97-116, 2006.
14. Sousa JM, Knobel M, Buchelle G, et al. Transient ventricular dysfunction (Takotsubo cardiomyopathy). Arq Bras Cardiol 2005 Apr; 84: 340-2Epub 2005 May 2 (in Portuguese, Abstract in English).
15. Wang Q, Chen Q, Towbin JA. Genetics, molecular mechanisms and management of long QT syndrome. Ann Med 30: 58-65, 1989.